[DOI] [PMC free article] [PubMed] [Google Scholar] 20.Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jni P, Lettino M, Marx N, Mellbin LG, stgren CJ, Rocca B, Roffi M, Sattar N, Seferovi PM, Sousa-Uva M, Valensi P, Wheeler DC, ESC Scientific Document Group ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) Eur Heart J
This is the step where many people ask about why they are not losing weight on semaglutide or whether to slow down titration
Only Wegovy (semaglutide) is FDA-approved specifically for weight management in people without diabetes
Injection site reactions including redness, itching, or swellingmay occur but are generally mild and transient